Andros Pharmaceuticals Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Andros Pharmaceuticals Co Ltd

Watchlist Manager

Watchlist

Price: 32.5 TWD Market Closed

Market Cap: NT$1.8B

A	Andros Pharmaceuticals Co Ltd TPEX:6917	TW
	Autostrade Meridionali SpA MIL:AUTME	IT
	Dualtap Co Ltd TSE:3469	JP

Profitability Summary

Andros Pharmaceuticals Co Ltd's profitability score is 6/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-3%

Sustainable 3Y Average Gross Margin

22%

Declining Gross Margin

52% > -3%

Negative Operating Margin

-47.564%

Negative 3Y Average Operating Margin

-30.318%

Declining Operating Margin

-4.493% > -47.564%

Negative Net Margin

-47.760%

Negative 3Y Average Net Margin

-28.259%

Declining Net Margin

-4.093% > -47.760%

Negative Free Cash Flow Margin

-46.053%

Negative 3Y Average Free Cash Flow Margin

-27.684%

Declining Free Cash Flow Margin

-3.085% > -46.053%

Negative ROE

-23%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-96%

Declining ROIC

-75% > -87%

View All

Hide

Collapse

6 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.